About Scott Tomlins
Dr. Tomlins earned a BA in Biology, from Willamette University in Salem, Oregon, a PhD in Molecular and Cellular Pathology from the University of Michigan, Ann Arbor, and is currently in his last year of the MD/PhD program at the University of Michigan Medical School. He will begin his residency in Pathology at the University of Michigan in July of 2009.
Specific chromosomal rearrangements in more than half of prostate cancers, using a novel analysis of DNA microarray data, were identified in 2005. These rearrangements result in the fusion of two genes that are normally located on separate chromosomes. These gene fusions become rational targets for prostate cancer therapy and also can be used for diagnosis. Dr. Tomlins proposes to work on developing tests for the early diagnosis of prostate cancer using these gene fusions as well as characterizing additional dysregulated genes in prostate cancer.
Arul Chinnaiyan, MD, PhD, an eminent professor of pathology and urology who specializes in molecular profiling of cancer at the University of Michigan Medical School, will provide mentorship for Dr. Tomlins.
2007 The Safeway Foundation – PCF Young Investigator Award
Scott Tomlins, PhD
University of Michigan – Ann Arbor, MI